S-Equol improves type 2 diabetes mellitus combined with nonalcoholic fatty liver disease by regulating SREBP pathway and PPARγ in rats

Objective To analyze the effects of S-Equol on glucose and lipid metabolism in rats with type 2 diabetes mellitus (T2DM) and nonalcoholic fatty liver disease (NAFLD). Methods Fifty SD rats aged 6 weeks were randomly divided into the control group (n=10) and the modeling group (n=40) after 1 week's a...

ver descrição completa

Detalhes bibliográficos

Principais autores:	XU Zhe, NI Xiangmin, LI Shuo, ZHANG Guiming, CUI Hanqiang, WANG Jian
Formato:	Artigo
Idioma:	Chinês
Publicado em:	Editorial Office of Journal of Army Medical University 2022-11-01
coleção:	陆军军医大学学报
Assuntos:	s-equol rat type 2 diabetes non-alcoholic fatty liver disease
Acesso em linha:	http://aammt.tmmu.edu.cn/Upload/rhtml/202206081.htm
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!